294 related articles for article (PubMed ID: 21994790)
1. Cell surface markers in HTLV-1 pathogenesis.
Kress AK; Grassmann R; Fleckenstein B
Viruses; 2011 Aug; 3(8):1439-59. PubMed ID: 21994790
[TBL] [Abstract][Full Text] [Related]
2. Role of the HTLV-1 viral factors in the induction of apoptosis.
Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
4. Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.
Maksimova V; Panfil AR
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062342
[TBL] [Abstract][Full Text] [Related]
5. Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein.
Jain P; Mostoller K; Flaig KE; Ahuja J; Lepoutre V; Alefantis T; Khan ZK; Wigdahl B
J Biol Chem; 2007 Nov; 282(47):34581-93. PubMed ID: 17897946
[TBL] [Abstract][Full Text] [Related]
6. Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.
Kress AK; Schneider G; Pichler K; Kalmer M; Fleckenstein B; Grassmann R
J Virol; 2010 Sep; 84(17):8732-42. PubMed ID: 20573814
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 Tax and adult T-cell leukemia.
Giam CZ; Jeang KT
Front Biosci; 2007 Jan; 12():1496-507. PubMed ID: 17127397
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
9. Latency Reversing Agents: Kick and Kill of HTLV-1?
Schnell AP; Kohrt S; Thoma-Kress AK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073995
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
Johnson JM; Harrod R; Franchini G
Int J Exp Pathol; 2001 Jun; 82(3):135-47. PubMed ID: 11488989
[TBL] [Abstract][Full Text] [Related]
11. The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation.
Kfoury Y; Nasr R; Journo C; Mahieux R; Pique C; Bazarbachi A
Adv Cancer Res; 2012; 113():85-120. PubMed ID: 22429853
[TBL] [Abstract][Full Text] [Related]
12. c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.
Hieshima K; Nagakubo D; Shigeta A; Tanaka Y; Hoshino H; Tsukasaki K; Yamada Y; Yoshie O
Cancer Sci; 2011 Apr; 102(4):890-4. PubMed ID: 21244576
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
14. Adult T-cell leukemia/lymphoma and HTLV-1.
Mahieux R; Gessain A
Curr Hematol Malig Rep; 2007 Oct; 2(4):257-64. PubMed ID: 20425378
[TBL] [Abstract][Full Text] [Related]
15. Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
17. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
18. Correlation of HTLV-1 Tax genetic diversity with HTLV-1 associated myelopathy/tropical spastic paraparesis progression and HTLV-1a genotypes in an HTLV-1 endemic region in Argentina.
Iñiguez AM; Gastaldello R; Otsuki K; Balangero M; Carvalho Costa F; Remondegui C; Paula Vicente AC; Gallego S
J Med Virol; 2010 Aug; 82(8):1438-41. PubMed ID: 20572090
[TBL] [Abstract][Full Text] [Related]
19. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.
Yamano Y; Takenouchi N; Li HC; Tomaru U; Yao K; Grant CW; Maric DA; Jacobson S
J Clin Invest; 2005 May; 115(5):1361-8. PubMed ID: 15864353
[TBL] [Abstract][Full Text] [Related]
20. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
